| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.091 | 0.1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |